AU Stock MarketDetailed Quotes
PAR Paradigm Biopharmaceuticals Ltd
- 0.192
- -0.003-1.54%
20min DelayTrading Oct 1 10:26 AET
67.27MMarket Cap-960P/E (Static)
0.195High0.190Low170.31KVolume0.195Open0.195Pre Close33.05KTurnover0.78052wk High0.05%Turnover Ratio350.36MShares0.16552wk Low-0.2EPS TTM60.30MFloat Cap4.500Historical HighLossP/E (Static)314.05MShs Float0.165Historical Low-0.2EPS LYR2.56%Amplitude--Dividend TTM2.82P/B1Lot Size--Div YieldTTM
Paradigm Biopharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | (FY)Jun 30, 2020 | (Q4)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -68.37%17.82M | -68.37%17.82M | 41.99%56.33M | 41.99%56.33M | -44.15%39.67M | -44.15%39.67M | -31.65%71.03M | -31.65%71.03M | 31.82%103.92M | 31.82%103.92M |
| -Cash and cash equivalents | -68.37%17.82M | -68.37%17.82M | 41.99%56.33M | 41.99%56.33M | -44.15%39.67M | -44.15%39.67M | -31.65%71.03M | -31.65%71.03M | 43.67%103.92M | 43.67%103.92M |
| -Accounts receivable | ---- | ---- | ---- | ---- | -10.79%18.33K | -10.79%18.33K | --20.55K | --20.55K | ---- | ---- |
| -Notes receivable | -5.13%107.04K | -5.13%107.04K | 47.77%112.83K | 47.77%112.83K | -29.44%76.36K | -29.44%76.36K | 58.22%108.21K | 58.22%108.21K | --68.39K | --68.39K |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%36.59K | 0.00%36.59K |
| Holding assets for sale | 0.00%46.2K | 0.00%46.2K | 0.00%46.2K | 0.00%46.2K | 0.00%46.2K | 0.00%46.2K | -93.81%46.2K | -93.81%46.2K | --746.2K | --746.2K |
| Total current assets | -61.98%24.25M | -61.98%24.25M | 35.22%63.79M | 35.22%63.79M | -41.75%47.17M | -41.75%47.17M | -25.28%80.98M | -25.28%80.98M | 31.35%108.37M | 31.35%108.37M |
| Non current assets | ||||||||||
| -Accumulated depreciation | -21.28%-836.33K | -21.28%-836.33K | -13.32%-689.6K | -13.32%-689.6K | -46.54%-608.51K | -46.54%-608.51K | -101.53%-415.26K | -101.53%-415.26K | -585.44%-206.06K | -585.44%-206.06K |
| -Long term equity investment | -50.36%117.49K | -50.36%117.49K | -49.52%236.69K | -49.52%236.69K | -24.03%468.91K | -24.03%468.91K | -17.59%617.23K | -17.59%617.23K | --748.96K | --748.96K |
| -Goodwill | 0.00%2.95M | 0.00%2.95M | 0.00%2.95M | 0.00%2.95M | 0.00%2.95M | 0.00%2.95M | 0.00%2.95M | 0.00%2.95M | -1.13%2.95M | -1.13%2.95M |
| Regulatory assets | -25.34%5.08M | -25.34%5.08M | 1.32%6.81M | 1.32%6.81M | -21.03%6.72M | -21.03%6.72M | 142.40%8.51M | 142.40%8.51M | -0.64%3.51M | -0.64%3.51M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | 16.07%121.84K | 16.07%121.84K | -28.96%104.97K | -28.96%104.97K | 9.76%147.76K | 9.76%147.76K | 7.93%134.62K | 7.93%134.62K | --124.73K | --124.73K |
| -Current capital lease obligation | 16.07%121.84K | 16.07%121.84K | -28.96%104.97K | -28.96%104.97K | 9.76%147.76K | 9.76%147.76K | 7.93%134.62K | 7.93%134.62K | --124.73K | --124.73K |
| -accounts payable | -76.80%2.82M | -76.80%2.82M | 71.57%12.16M | 71.57%12.16M | 42.15%7.09M | 42.15%7.09M | 81.47%4.99M | 81.47%4.99M | 20.55%2.75M | 20.55%2.75M |
| -Total tax payable | -35.76%224.53K | -35.76%224.53K | -35.90%349.52K | -35.90%349.52K | -24.84%545.27K | -24.84%545.27K | -11.25%725.43K | -11.25%725.43K | --817.35K | --817.35K |
| Current liabilities | -74.24%3.36M | -74.24%3.36M | 66.55%13.04M | 66.55%13.04M | 35.17%7.83M | 35.17%7.83M | 72.19%5.79M | 72.19%5.79M | 24.40%3.36M | 24.40%3.36M |
| Non current liabilities | ||||||||||
| -Long term debt | -50.36%117.49K | -50.36%117.49K | -49.52%236.69K | -49.52%236.69K | -24.03%468.91K | -24.03%468.91K | -17.59%617.23K | -17.59%617.23K | --748.96K | --748.96K |
| Non current accrued expenses | -43.62%189.66K | -43.62%189.66K | -41.10%336.39K | -41.10%336.39K | -25.28%571.16K | -25.28%571.16K | -18.92%764.41K | -18.92%764.41K | 3,823.72%942.83K | 3,823.72%942.83K |
| Employee benefits | -5.13%107.04K | -5.13%107.04K | 47.77%112.83K | 47.77%112.83K | -29.44%76.36K | -29.44%76.36K | 58.22%108.21K | 58.22%108.21K | --68.39K | --68.39K |
| Preferred securities outside stock equity | -46.30%416.81K | -46.30%416.81K | 30.46%776.2K | 30.46%776.2K | -11.52%594.96K | -11.52%594.96K | 47.62%672.4K | 47.62%672.4K | 17.22%455.51K | 17.22%455.51K |
| Total non current liabilities | -73.23%3.58M | -73.23%3.58M | 59.88%13.39M | 59.88%13.39M | 28.49%8.38M | 28.49%8.38M | 55.88%6.52M | 55.88%6.52M | 54.62%4.18M | 54.62%4.18M |
| Shareholders'equity | ||||||||||
| Share capital | 13.48%238.11M | 13.48%238.11M | 42.56%209.83M | 42.56%209.83M | 0.14%147.19M | 0.14%147.19M | 0.77%146.99M | 0.77%146.99M | 33.25%145.87M | 33.25%145.87M |
| -common stock | 13.48%238.11M | 13.48%238.11M | 42.56%209.83M | 42.56%209.83M | 0.14%147.19M | 0.14%147.19M | 0.77%146.99M | 0.77%146.99M | 33.25%145.87M | 33.25%145.87M |
| Gains losses not affecting retained earnings | -12.71%6.42M | -12.71%6.42M | -19.44%7.36M | -19.44%7.36M | 40.25%9.13M | 40.25%9.13M | 81.64%6.51M | 81.64%6.51M | -11.97%3.59M | -11.97%3.59M |
| Total equity | -59.16%27.39M | -59.16%27.39M | 32.32%67.07M | 32.32%67.07M | -40.22%50.69M | -40.22%50.69M | -24.54%84.79M | -24.54%84.79M | 31.40%112.36M | 31.40%112.36M |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data